PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
877.13%
Growth of 877.13% while CRON.TO shows flat revenue. Bruce Berkowitz would examine growth quality advantage.
-40.51%
Cost reduction while CRON.TO shows 48.78% growth. Joel Greenblatt would examine competitive advantage.
177.09%
Positive growth while CRON.TO shows decline. John Neff would investigate competitive advantages.
-76.50%
Margin decline while CRON.TO shows 0.00% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
-76.75%
G&A reduction while CRON.TO shows 176.48% growth. Joel Greenblatt would examine efficiency advantage.
83.85%
Marketing expense change of 83.85% while CRON.TO maintains spending. Bruce Berkowitz would investigate effectiveness.
102.73%
Other expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
-65.72%
Operating expenses reduction while CRON.TO shows 146.03% growth. Joel Greenblatt would examine advantage.
-66.24%
Total costs reduction while CRON.TO shows 135.50% growth. Joel Greenblatt would examine advantage.
-16.03%
Interest expense reduction while CRON.TO shows 1582.10% growth. Joel Greenblatt would examine advantage.
-4.44%
Both companies reducing D&A. Martin Whitman would check industry patterns.
84.96%
EBITDA growth while CRON.TO declines. John Neff would investigate advantages.
98.46%
Margin change of 98.46% while CRON.TO is flat. Bruce Berkowitz would examine quality.
-20.78%
Operating income decline while CRON.TO shows 575.95% growth. Joel Greenblatt would examine position.
87.64%
Margin change of 87.64% while CRON.TO is flat. Bruce Berkowitz would examine quality.
101.43%
Other expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
83.07%
Pre-tax income growth below 50% of CRON.TO's 508.61%. Michael Burry would check for structural issues.
98.27%
Margin change of 98.27% while CRON.TO is flat. Bruce Berkowitz would examine quality.
99.36%
Tax expense growth while CRON.TO reduces burden. John Neff would investigate differences.
83.07%
Net income growth below 50% of CRON.TO's 542.15%. Michael Burry would check for structural issues.
98.27%
Margin change of 98.27% while CRON.TO is flat. Bruce Berkowitz would examine quality.
83.25%
EPS growth below 50% of CRON.TO's 935.85%. Michael Burry would check for structural issues.
83.25%
Diluted EPS growth below 50% of CRON.TO's 935.85%. Michael Burry would check for structural issues.
0.59%
Share count reduction exceeding 1.5x CRON.TO's 22.56%. David Dodd would verify capital allocation.
0.59%
Diluted share reduction exceeding 1.5x CRON.TO's 22.56%. David Dodd would verify capital allocation.